Dr. Reddy's Laboratories Limited (BOM:500124)
India · Delayed Price · Currency is INR 1,253.60
-17.45 (-1.37%)
At close: Jan 1, 2026
Dr. Reddy's Laboratories Employees
Dr. Reddy's Laboratories had 27,811 employees as of March 31, 2025. The number of employees increased by 763 or 2.82% compared to the previous year.
Employees
27,811
Change (1Y)
763
Growth (1Y)
2.82%
Revenue / Employee
12.30M INR
Profits / Employee
2.11M INR
Market Cap
1.04T
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 27,811 | 763 | 2.82% |
| Mar 31, 2024 | 27,048 | 1,185 | 4.58% |
| Mar 31, 2023 | 25,863 | 1,068 | 4.31% |
| Mar 31, 2022 | 24,795 | 2,056 | 9.04% |
| Mar 31, 2021 | 22,739 | 1,089 | 5.03% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Tata Consultancy Services | 607,979 |
| Reliance Industries | 403,303 |
| Infosys | 323,578 |
| State Bank of India | 236,226 |
| HDFC Bank | 214,521 |
| ICICI Bank | 182,665 |
| Life Insurance Corporation of India | 91,606 |
| Bajaj Finance | 64,092 |
Dr. Reddy's Laboratories News
- 2 days ago - Dr Reddy, Cipla, Sun Pharma and other stocks in focus today as Govt bans high-dose Nimesulide formulations - Business Upturn
- 8 days ago - Nifty 50 top losers today, December 24: IndiGo, Dr. Reddy’s, Wipro, Adani Enterprises, HDFC Life, Tata Motors PV and more - Business Upturn
- 9 days ago - Dr Reddy’s Laboratories shares in focus as company’s semaglutide not approved in Canada – Know More - Business Upturn
- 9 days ago - Dr Reddy’s semaglutide not approved in Canada as Health Canada flags regulatory gaps: Report - Business Upturn
- 20 days ago - Dr. Reddy’s Laboratories receives five observations following USFDA inspection at Srikakulam facility - Business Upturn
- 21 days ago - Dr. Reddy’s Laboratories announces SBTi-approved Net Zero targets for FY2045 - Business Upturn
- 23 days ago - Zacks Industry Outlook Highlights Sandoz, Teva Pharmaceuticals and Dr. Reddy's - Nasdaq
- 24 days ago - Dr. Reddy’s Laboratories enters strategic collaboration with Immutep SAS for exclusive licensing of eftilagimod alfa - Business Upturn